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Abstract
Background: Growing evidence indicates that oxidative stress can be a primary cause of male infertility. Non-
enzymatic antioxidants play an important protective role against oxidative damages and lipid peroxidation. Human
seminal plasma is a natural reservoir of antioxidants. The aim of this study was to determine glutathione (GSH)
concentrations, trace element levels (zinc and selenium) and the lipid peroxidation end product, malondialdehyde
(MDA), in the seminal plasma of men with different fertility potentials.
Methods: Semen samples from 60 fertile men (normozoospermics) and 190 infertile patients (74
asthenozoospermics, 56 oligozoospermics, and 60 teratozoospermics) were analyzed for physical and biochemical
parameters. Zinc (Zn) and selenium (Se) levels were estimated by atomic absorption spectrophotometry. Total GSH
(GSHt), oxidized GSH (GSSG), reduced GSH (GSHr) and MDA concentrations were measured spectrophotometrically.
Results: Zn and Se concentrations in seminal plasma of normozoospermics were more elevated than the three
abnormal groups. Nevertheless, only the Zn showed significant differences. On the other hand, Zn showed positive
and significant correlations with sperm motility (P = 0.03, r = 0.29) and count (P < 0.01, r = 0.49); however Se was
significantly correlated only with sperm motility (P < 0.01, r = 0.36). GSHt, GSSG and GSHr were significantly higher
in normozoospermics than in abnormal groups. We noted a significant association between seminal GSHt and
sperm motility (P = 0.03). GSSG was highly correlated to sperm motility (P < 0.001) and negatively associated to
abnormal morphology (P < 0.001). GSHr was significantly associated to total sperm motility (P < 0.001) and sperm
count (P = 0.01). MDA levels were significantly higher in the three abnormal groups than in normozoospermics.
Rates of seminal MDA were negatively associated to sperm motility (P < 0.01; r = -0.24) and sperm concentration
(P = 0.003; r = -0.35) Meanwhile, there is a positive correlation between seminal lipid peroxidation and the
percentage of abnormal morphology (P = 0.008).
Conclusions: This report revealed that decreased seminal GSH and trace element deficiencies are implicated in
low sperm quality and may be an important indirect biomarker of idiopathic male infertility. Our results sustain that
the evaluation of seminal antioxidant status in infertile men is necessary and can be helpful in fertility assessment
from early stages.
Keywords: Antioxidants, Idiopathic oligoasthenoteratozoospermia, Male infertility, Oxidative stress, Reactive oxygen
species, Spermatozoa, Seminal plasma
Background
It is increasingly recognized that reactive oxygen species
(ROS) are of significant pathophysiological importance
in the etiology of male infertility [1]. ROS are highly
reactive oxidizing agents belonging to the class of free
radicals containing one or more unpaired electrons
which are continuously being generated through meta-
bolic and pathophysiologic processes [2]. It has been
postulated that oxidants interfere with normal sperm
function via membrane lipid peroxidation and fragmen-
tation of nucleic acids, which result in sperm dysfunc-
tion [3]. Due to their abundance of membrane
polyunsaturated fatty acids (PUFAs) and their capacity
to generate ROS, human spermatozoa are highly
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marker of lipid peroxidation is MDA. This by-product
has been used in biochemical assays to monitor the
degree of peroxidative damage sustained by spermato-
zoa. The results of such assay exhibit an excellent corre-
lation with the degree to which sperm function is
impaired [4]. High levels of seminal MDA represent
increased lipid peroxidation rates, which diminishes fer-
tility [3,4].
Hence, human spermatozoa are known to possess all
of the major antioxidant defensive systems’ including
catalase, superoxide dismutase (SOD), glutathione per-
oxidase (GPX) and glutathione reductase (GRD) [5],
their effectiveness is impaired by their limited concen-
trations and distribution. Interestingly, the seminal
plasma is well equipped with an array of antioxidant
defence mechanisms to protect the spermatozoa against
oxidants. Antioxidants that are present in the seminal
plasma compensate for the deficiency in cytoplasmic
enzymes in the spermatozoa [4]. The activities of semi-
nal antioxidant enzymes like SOD and GPX, has been
measured in several studies [5]. Additionally, low mole-
cular weight scavengers from seminal plasma appeared
to be more important than enzymes, for example, trace
elements and GSH [1,5].
Trace elements in human semen comprising Zn and
Se have been shown to be essential for testicular devel-
opment and spermatogenesis [6-9]. Zn is one of the pri-
mary factors responsible for deoxyribonucleic acid
(DNA) transcription and protein synthesis which are
major parts of sperm development [8]. Its concentra-
tions are very high in the male genital organs, particu-
larly in the prostate gland [7]. Zn can oppose the
oxidation by binding sulphydryl groups in proteins and
by occupying binding sites for copper in lipids and
DNA [8]. It can also be a cofactor of Copper/Zn-SOD
[6]. Recent studies hypothesized that insufficient intake
of Zn impairs antioxidant defences. This may be an
important risk factor in oxidant release and makes the
spermatozoa more susceptible to lipid peroxidation [6].
Se, in particular, is an essential element for normal
testicular development, spermatogenesis, and spermato-
z o am o t i l i t ya n df u n c t i o n[ 9 ]. Se may protect against
oxidative DNA damage in human sperm cells. However,
the exact mechanism by which Se eliminates oxidative
stress to improve male fertility and semen quality in
humans is still controversial. The role of Se could be
mediated via selenoenzymes, such as GPX [10]. The
best-characterized spermatozoal effects of Se deficiency
are: important loss of motility, breakage at the midpiece
level [9,10] and increased incidence of sperm-shape
abnormalities, mostly of the sperm head [10].
One more important antioxidant in humans is GSH [3].
It serves as a cofactor for GPX and reacts directly with
ROS by its free sulphydryl groups. When present in extra-
cellular space, GSH is able to react directly with cytotoxic
aldehydes produced during lipid peroxidation and thus
protects the sperm plasma membrane [11]. GSHt is an
imperative antioxidant via its ability to cycle between
GSHr and GSSG. GSHt scavenges excess ROS and oxi-
dized to GSSG, which is subsequently converted back to
GSHr via GRD. The fertility promoting role of GSH has
been established through different studies where GSH has
been found to be reduced in oligozoospermics and azoos-
permics compared to normozoospermics [12].
Keeping in view the main protection provided by
seminal plasma antioxidants against oxidative damages,
the purpose of our present study was to (1) evaluate the
non-enzymatic antioxidant profiles of idiopathic infertile
men and to (2) assess their impact on semen para-
meters. In order to fulfil this goal, we measured the con-
centrations of Zn, Se, GSH and MDA in the seminal
plasma of 250 infertile men. To our knowledge, this
report which investigated the repercussions of human
seminal antioxidants on sperm quality constitutes the
first one conducted in Tunisia.
Methods
Study design and subject selection
A prospective controlled study was employed, involving
250 men (22-50 years) consulting for infertility evalua-
tion in our laboratory of Cytogenetic and Reproductive
Biology, Farhat Hached University Hospital, Sousse
(Tunisia). Inclusion and exclusion criteria for selection
of idiopathic infertile males were as follows:
Inclusion criteria
Males of couples living together with regular unpro-
tected coitus for a reasonable period of time but not
less than 1 year without conception.
Exclusion criteria
A detailed medical history was performed for all studied
cases. Subjects currently on any medication or antioxi-
dant supplementation were not included. In addition,
subjects with testicular varicocele, genital infection, leu-
kocytospermia, chronic illness and serious systemic dis-
eases, smokers and alcoholic men were excluded from
the study because of their well-known high seminal
ROS levels and decreased antioxidant activity.
Study consent
A written consent of each subject was taken after
explaining the aims and objectives of the study and its
benefits on individual and society. Also, the study was
approved by the Local Ethic Committee of the Farhat
Hached University Hospital, Sousse (Tunisia).
Semen analysis
Semen samples were collected by masturbation into
sterile cups following 3 days of sexual abstinence. After
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(Volume, motility, concentration and morphology) were
immediately evaluated according to the World Health
Organization guidelines (1999) [13]. Sperm motility was
classified into four categories: rapid progressive motile
(Type a), slow progressive motile (Type b), non-progres-
sive motile and immotile spermatozoa, and was assayed
at exactly 0.5 and 2 hours after liquefaction.
Total progressive motility was defined as the combina-
tion of type a rapid motility and type b slow progressive
(At least 30% of sperm should have normal motility
(categories a + b)). Sperm concentration was determined
with an improved Neubauer Hemacytometer
® counting
chamber and normal values of concentration were “ >
20 × 106 sperm/ml”. Morphology was measured by
recording the percentage of abnormal forms in the sam-
ple based on the classification of “David” [14] and at
least 30% of sperm should have normal morphology.
After semen analysis, selected subjects were divided
into four categories (Details of groups and semen char-
acteristics were described in Tables 1 and 2):
a. Normozoospermics-Normo [60 cases]: Subjects of
this group represent fertile men (controls). They are
characterized by normal values for sperm motility (>
30%), sperm concentration (> 20 × 106 sperm/ml) and
normal sperm morphology (> 30%).
b. Asthenozoospermics-Astheno [74 cases]: This
study group consists of isolated asthenozoospermic men
whose infertility is determined mainly by less than nor-
mal levels for sperm motility (< 30%), with normal
values of morphologically normal sperm (< 30%) and
sperm concentration (> 20 × 106 sperm/ml).
c. Oligozoospermics-Oligo [56 cases]: Infertility of this
group is defined mainly by an isolated oligozoospermia
(< 20 × 106 sperm/ml), with normal levels for sperm moti-
lity (> 30%) and morphologically normal sperm (> 30%)
d. Teratozoospermics-Terato [60 cases]: This cate-
gory of patients consists of isolated teratozoospermic
men whose infertility is determined essentially by less
than normal levels for morphologically normal sperm (<
30%), with normal values of sperm concentration (> 20
× 106 sperm/ml) and motility (> 30%).
After semen analysis, seminal plasma was separated
from spermatozoa by centrifugation at 3500 rpm for 15
minutes and stored at -80°C until antioxidant analysis.
Chemicals
All reagents and chemicals were of analytical grade or
higher purity and obtained from standard commercial
suppliers. Ultra-pure water was received from water
purification Milli-Q system (Millipore Corporation,
USA).
Biochemical Procedures
a. Analytical methods for determination of Zn and Se
levels
For all the experiment, flame atomic absorption spec-
trophotometry (AAS) was adopted for Zn determination
and furnace AAS for Se measurement. The measures
were implemented using a Zeenit 700-Analytik-Jena,
Germany, equipped with deuterium and Zeeman back-
ground correction, respectively, as recommended by the
manufacturer. Detection limits for these microelements
were as follows: Zn (0.47 μg/l) and Se (0.78 μg/l).
b. Determination of GSHt and GSSG contents
GSHt and GSSG levels were measured spectrophoto-
metrically in deproteinized seminal plasma samples, by
the method of Akerboom & Sies, (1981) [15], using 5,5’-
Table 1 General characteristics of the studied population
parameters Characteristics Number(n) Percentage (%)
Age (Years) ≤ 35 105 42
> 35 145 58
Duration of infertility ≤ 10 183 72.2
> 10 67 28.8
Type of infertility Primary 191 76.4
Secondary 59 32.6
Area Rural 94 37.6
Urban 156 62.4
Diet Vegetarian 138 55.2
Mixed 112 54.8
Sperm criteria Fertile 60 24
Asthenozoospermics 74 29.6
Oligozoospermics 56 22.4
Teratozoospermics 60 24
Duration of sexual abstinence (Days) 3 250 100
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compared with standard curves from known amounts of
GSH standards.
c. Assessment of oxidative stress by measurement
of Lipid Peroxidation
Lipid peroxidation was measured by determining the
MDA production, using the Thiobarbituric Acid (TBA)
method (Yagi, (1976)) [16]. After liquefaction, semen sam-
ples were centrifuged at 3500 rpm for 15 min to get semi-
nal plasma. Then, 0.1 ml of seminal plasma was added to
0.75 ml of TBA reagent (0.8 g of 2-TBA dissolved in 80 ml
of distilled water with 0.5 ml of NaOH. Perchloric acid
(7%) was added to this mixture in order to adjust the pH
= 7.4). This mixture was heated for 1 hour at 95°C in a
warm water bath. After cooling, the tube was centrifuged
for 10 min at 4000 rpm and the supernatant’s absorbance
was read on a spectrophotometer at 535 nm.
Statistical analysis
The Windows computing program Statistical Package for the
Social Sciences “SPSS 11.0” (SPSS, Chicago, IL, USA) was
used for analyzing the data. All data were expressed as mean
± standard deviation (S.D.). The differences that existed
between the evaluated study groups were assessed by per-
forming an analysis of varian c e( O n e - w a yA N O V A )a n dt h e
post hoc test (Tukey test) to conduct pair-wise comparisons.
The differences were considered to be significant at values of
P ≤ 0.05. Finally, Pearson’s correlation was performed to
examine the correlation between trace elements, MDA and
semen quality. All hypothesis testing were two-sided with a
probability value of 0.05 deemed as significant (P < 0.05 =
significant*; P < 0.001 = highly significant**).
Results
A ss h o w ni nT a b l e2t h em e a no fa g eo ft h ef e r t i l e
group (33.4 ± 4.4 years) was decreased when compared
to asthenozoospermics (34.9 ± 4.2 years), oligozoosper-
mics (40.2 ± 4.5 years) and teratozoospermics (39 ± 5
years), but the difference was not significant. There was
no significant correlation between patient’sa g ea n d
seminal antioxidant status. The mean values of the
examined sperm parameters in controls and infertile
groups are shown in Table 2. Sperm count, motility and
the percentage of normal morphology were significantly
higher in normozoospermics than the three abnormal
groups.
Trace element and GSH levels
In this study and as shown in Table 3, concentrations of
seminal trace elements “Zn and Se” were more elevated
in the control group than the three abnormal groups.
However, only the Zn showed significantly differences
after comparison between controls and asthenozoosper-
mics (P = 0.02), oligozoospermics (P = 0.008) and tera-
tozoospermics (P = 0.04). Moreover, a significant
increase of mean GSHt were found in normozoosper-
mics (57.00 ± 19.54 μmol/l) compared to asthenozoos-
permics (38.41 ± 23.92 μmol/l P < 0.001) and
teratozoospermics (45.77 ± 17.62 μmol/l P = 0.002).
Also, a highly significant decline in GSSG concentration
was detected in the seminal plasma of teratozoospermics
compared to the fertile group (P < 0.001) (Table 3).
GSHr showed an increased concentration in normo-
zoospermic group compared to Asthenozoospermics (P
< 0.001); however, there was no significant difference
observed when compared with oligozoospermics and
teratozoospermics.
Seminal MDA content
Lipid peroxidation as expressed by MDA level in the
seminal plasma was found to be significantly higher in
the three abnormal groups than in fertile group. Mean
Table 2 Descriptive statistics and comparison of conventional semen parameters fertile and the three infertile groups
Parameters Fertile
(n = 60)
Astheno
(n = 74)
Oligo
(n = 56)
Terato
(n = 60)
P-Value
Fertile Vs Astheno Fertile Vs Oligo Fertile Vs Terato
Age (years) 33.43 ± 4.40 34.95 ± 4.20 40.27 ± 4.50 39.00 ± 5.01 NS NS NS
Mean ± SD Min-Max 22.00-41.00 29.00-42.00 30.00-50.00 28.00-50.00
Volume (ml) 3.89 ± 1.48 3.34 ± 1.67 4.21 ± 2.44 3.65 ± 1.73 NS NS NS
Mean ± SD Min-Max 2.00-5.56 2.00-7.58 2.00-8.23 2.00-6.34
Sperm motility (%) 48.72 ± 14.22 18.40 ± 9.62 45.72 ± 13.42 44.32 ± 12.45 P < 0.001 NS NS
Mean ± SD Min-Max 43.00-100 1.00-30.00 40.00-99.00 40.00-97.00
Sperm Count (x10
6/ml) 75.86 ± 23.83 46.21 ± 24 9.56 ± 6.51 54.00 ± 26.23 P < 0.001 P < 0.001 0.001
Mean ± SD Min-Max 30.00-100 20.00-100 1.00-15.00 26.00-100
Abnormal morphology (%) 60.90 ± 13.28 60.42 ± 11.85 65.24 ± 16.36 81.79 ± 11.49 NS NS P < 0.001
Mean ± SD Min-Max 39.00-65.00 41.00-72.00 41.00-69.00 77.00-98.00
Note: Astheno = Asthenozoospermics, Oligo = Oligozoospermics, Terato = Teratozoospermics, Max = maximum, Min = minimum, ml = milliliter, SD = Standard
Deviation. Data are expressed as means ± SD. NS = Not significant. P ≤ 0.05 = significant.
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± 1.93 μmol/l in the asthenozoospermic group,
3.21 ± 1.37 μmol/l in the oligozoospermic group and
3.64 ± 1.73 μmol/l in the teratozoospermic group (Table
3). In effect, rates of seminal MDA were negatively asso-
ciated to sperm motility (P < 0.01; r = -0.24) and sperm
concentration (P = 0.003; r = -0.35) Meanwhile, there
was a positive correlation between seminal lipid peroxi-
dation and the percentage of abnormal morphology (P =
0.008; r = 0.19) (Table 4).
Correlations between seminal antioxidant status and
sperm parameters
Significant positive correlations were detected between
seminal Zn concentrations and sperm motility (P = 0.03,
r = 0.29) and sperm concentration (P < 0.01, r = 0.49).
Seminal Se showed a highly significant relationship only
with sperm motility (P < 0.01, r = 0.36) (Table 4).
As shown in Table 4 we noted a significant association
between seminal GSHt and sperm motility (P = 0.03, r =
0.13). However, seminal GSSG was highly correlated to
sperm motility (P < 0.001, r = 0.22) and negatively asso-
ciated to the percentage of sperm atypical forms (P <
0.001, r = -0.39) Seminal GSHr was significantly asso-
ciated to sperm motility (P < 0.001, r = 0.42) and sperm
concentration (P = 0.01, r = 0.11).
Discussion
The key results in this study were: (1) An impaired anti-
oxidant status was observed in seminal plasma of infer-
tile men. (2) The fertile group showed a significant
decrease in seminal lipid peroxidation levels compared
to the three abnormal groups. (3) Positive correlations
exist between enhanced seminal antioxidant status and
good semen quality. Total sperm motility was signifi-
cantly correlated to the seminal trace elements and dif-
ferent forms of GSH. The sperm concentration was
positively associated to the seminal Zn and seminal
GSHr amounts. However, the percentage of atypical
sperm forms showed a significantly negative relationship
to seminal GSSG. (4) Inversely to the non-enzymatic
antioxidants, seminal MDA levels were negatively corre-
lated to the sperm parameters. These findings indicated
that some idiopathic infertile men may be poorly
equipped to deal with oxidative stress due to the
impaired seminal antioxidant defences. As a conse-
quence, we suggest such a possibility and call for more
systematic research on the role of oxidative stress in
idiopathic male infertility.
The detailed biochemical mechanisms underlying the
physiopathology of male infertility are not clearly under-
stood. There has been evidence supporting the notion
Table 3 Seminal antioxidant status and MDA concentrations of the different studied groups
Parameters Fertile
(n = 60)
Astheno
(n = 74)
Oligo
(n = 56)
Terato (60) P-Value
Fertile Vs. Astheno Fertile Vs. Oligo Fertile VS. Terato
Zinc (mg/l) 144 ± 42.13 122 ± 34.69 120.51 ± 25.33 126 ± 24.82 0.02 0.008 0.04
Mean ± SD Min-Max 49.00-239 54.00-190 46.52-94.55 52-200
Selenium (μg/l) 64 ± 20.64 56.00 ± 22.81 55.00 ± 21.44 57.00 ± 24.31 NS NS NS
Mean Min-Max 44.00-84.00 30.00-72.00 41.00-69.00 36.00-76.00
GSHt (μmol/l) 57.00 ± 19.54 38.41 ± 23.92 52.86 ± 7.08 45.77 ± 17.62 < 0.001 NS 0.002
Mean ± SD Min-Max 25.63-99.55 7.18-96.84 43.88-60.86 14.22-68.45
GSSG (μmol/l) 22.81 ± 13.38 21.89 ± 12.67 24.84 ± 11.75 9.74 ± 5.82 NS NS < 0.001
Mean ± SD Min-Max 0.00-55.19 2.63-79.07 8.82-43.86 2.27-35.53
GSHr 34.27 ± 14.91 16.63 ± 12.83 28.00 ± 14.22 36.00 ± 16.71 < 0.001 NS NS
Mean ± SD Min-Max 19.00-55.00 13.00-31.00 13.85-43.00 19.00-42.00
MDA (μmol/l) 2.30 ± 0.94 3.52 ± 1.93 3.21 ± 1.37 3.64 ± 1.73 0.002 0.004 < 0.001
Mean ± SD Min-Max 1.37-2.33 2.21-4.83 2.28-4.29 2.66-4.68
Note: Astheno = Asthenozoospermics, Oligo = Oligozoospermics, Terato = Teratozoospermics, GSHt = Total glutathione, GSSG = Oxidized glutathione, GSHr =
reduced glutathione, MDA = Malondialdehyde acid, Max = maximum, Min = minimum, ml = millilitre, SD = Standard Deviation, NS = Not significant. Data are
expressed as means ± SD. P ≤ 0.05 = significant.
Table 4 The value of Pearson’s correlation coefficients
calculated between the antioxidant parameters and
sperm criteria
Elements Motility Sperm count Atypical forms
Zinc 0.29* 0.49** NS
Selenium 0.36** NS NS
GSHt 0.13* NS NS
GSSG 0.22** NS -0.39*
GSHr 0.42** 0.11* NS
MDA -0.24* -0.35* 0.19*
Note: GSHt = Total glutathione, GSSG = Oxidized glutathione, MDA =
Malondialdehyde acid, NS = Not significant. * Significant correlation P < 0.05,
** Correlation strongly significant P ≤ 0.001.
Atig et al. BMC Urology 2012, 12:6
http://www.biomedcentral.com/1471-2490/12/6
Page 5 of 8that major changes in seminal antioxidants could be
related to abnormal spermatozoa function and fertiliza-
tion capacity [9]. Hence, seminal plasma is considered
to be the central source of antioxidants that protect
sperm cells against oxidative damages. The antioxidant
system eliminates ROS to maintain a reduced environ-
ment in cells through enzymatic and non-enzymatic
approaches. The most studied antioxidants are the SOD,
GPX and catalase enzymes. Information about seminal
non-enzymatic antioxidants and male fertility potential
is quite inadequate till date. Moreover, it is important to
underline the contradictions and the controversial out-
comes found in the literature. In fact, these differences
can be due to several variables among which are inclu-
sion and exclusion criteria for patient selection, analyti-
cal methodologies, sperm anomalies (in our study, each
patient group has a single sperm anomaly; whether asth-
enozoospermia, or oligozoospermia or teratozoosper-
mia), lifestyle or dietary pattern and the patient’s origin.
In our study, we tried to explore the concentrations of
Zn, Se and GSH in the seminal plasma of our patient
groups and controls in order to estimate their contribu-
tion to maintain a good quality of sperm.
The mean seminal Zn concentrations in control and
abnormal groups were between 120 and 144 mg/l. These
values were comparable with a few similar studies
reported by Lewis Jones et al. (118 mg/l) [17] and Kruse
et al. (123 mg/l) [18]. However, the reported Zn levels in
other studies were considerably higher than our findings;
Omu et al. (171 mg/l) [19] and Chia et al. (183 mg/l) [7].
T h e s ed i f f e r e n c e sm a yb ed u et ot h es l i g h t l yd i f f e r e n t
techniques used in the measurement of Zn concentra-
tions and the difference in cigarette-smoking habits. In
comparison with the control group, our infertile patients
showed decreased seminal Zn concentrations; however
these differences were not significant. Inflammatory con-
ditions, prostatitis, accumulation of toxic heavy metals
and frequent ejaculation can negatively influence the
secretory function of the prostate and lead to a drop in
seminal Zn content [7,20]. Nevertheless, these factors
were excluded from our investigation and reduced Zn
amounts of infertile patients can be explained by other
mechanisms. Increased sperm ROS in infertile men
explain the decrease of seminal Zn concentrations, aris-
ing the harmful effects of ROS to sperm cells which are
associated with abnormal sperm parameters [8]. Powell
[21] supports this hypothesis, noting that reduction in Zn
concentration can lead to an increase in oxidation of
membrane lipids, DNA and proteins; which can provoke
the loss of membrane integrity. In our study, the negative
and not significant correlation between Zn and MDA
confirmed that reduction in seminal Zn levels is asso-
ciated to the decline of its antioxidant capacity and the
increase of lipid peroxidation and low sperm quality.
Additionally, seminal Zn concentrations demonstrated
significant differences between fertile and infertile men,
which corroborated with the findings of Colagar et al.
[6]. Furthermore, like Zaho et al. [22] we observed posi-
tive relationships between good sperm production, moti-
lity and increased seminal Zn content. With these
findings we can support the extensive evidence defend-
ing the antioxidant capacity of seminal Zn to yield var-
ious benefits in sperm including reduction of MDA and
decreasing of DNA fragmentation [10]. Therefore, Zn
m a yb eu s e f u li ni d i o p a t h i co l i goasthenoteratozoosper-
mia in reducing oxidative stress and the associated
sperm membrane and DNA damage [10].
Se is also an essential trace element that plays an
important role in a number of physiological processes
including human reproduction [22]. This element
becomes crucial for maintaining normal spermatogen-
esis and male fertility [23]. In our study, we reported a
slight increase of seminal Se in controls compared to
infertile groups. This was in agreement with the obser-
vations of Saaranen et al. [24] and Akinloye et al. [9]
who showed a significant decrease of seminal Se levels
in asthenozoospermics and oligozoospermics. Takasaki
et al. [25] did not find any difference in seminal Se
amounts between fertile and infertile men. Meanwhile, a
follow-up study 4.5-5 years after the initial assay
revealed that low Se levels (< 35 ng/ml) were associated
with male infertility.
Our findings sustain the data supporting the negative
influence of low seminal Se levels on the number of
spermatozoa and sperm motility [9,10]. This evidence
can be confirmed by the correlation of the seminal Se
and sperm motility observed in our investigation. The
association of Se with a protein present in the tail of
spermatozoa isolated from bulls and rats [26] and its
localization in the mitochondria capsule protein of the
midpiece [27] of spermatozoa are possible indications of
its importance in sperm motility and male infertility.
Decreased Se concentrations in seminal plasma of
infertile men were accompanied by increased levels of
seminal MDA of the same patients. In this respect, the
diminution of Se activity as an antioxidant can explain
the elevated lipid peroxidation in infertile patients. In
effect, the only biochemical role of Se in mammals
depends on its presence as a seleno-cysteine residue at
each of the four catalytic site of the enzyme “GPX” [9].
GPX plays a crucial role in the antioxidant defences of
the epididymis and the ejaculated spermatozoa [27].
In addition to the impaired Zn and Se concentrations
in seminal plasma of infertile men, we reported also
decreased seminal GSHt, GSSG and GSHr levels in the
three abnormal groups. Oshendorf et al. [28] found a
moderate reduction of GSH in oligozoospermic com-
pared to normozoospermic men, while other studies
Atig et al. BMC Urology 2012, 12:6
http://www.biomedcentral.com/1471-2490/12/6
Page 6 of 8found GSH levels below the limit of detection (< 2.5
μM) in seminal plasma of oligozoospermics, or GSH
levels to be significantly reduced in seminal plasma of
infertile males compared to those of fertile ones [1,3].
Even GSH therapy was found to improve the semen
quality [29]. Our results provide evidence that higher
levels of GSH in seminal plasma seem to play a role in
protection against oxidative damage and to improve the
sperm motility and morphology. While stating that,
other studies could not observe any difference in GSH
concentration between fertile and infertile men [8] and
this may be due to the contribution of spermatozoal
ROS leading to the up-regulation of thiol synthesis in
order to protect sperm from oxidative damage. Raij-
makers et al. [30] also reported that median levels of
seminal GSH were significantly lower in infertile males
as compared to normozoospermics, and found a positive
association between seminal GSH level and sperm mor-
phology and motility. In our investigation, we found
that higher GSHt, GSSG and GSHr levels in seminal
plasma were associated with a higher quality of sperm
motility and count, however lower GSSG levels were
associated with a higher degree of spermatozoa with
abnormal morphology and immobility. These findings
were compatible with that observed by Bhardwaj A et
al. [12] and Eskiocak S et al. [31].
Accordingly; we can suggest that the loss of sperm
motility in asthenozoospermic samples may result from
the over-oxidation of sperm sulphydryl. GSH displays
maximal staining in the mid-piece and tail region, which
are important regions for motility of spermatozoa [31].
These results imply that seminal plasma GSH levels may
play a role in the protection against oxidative damage by
reducing lipid peroxidati o no ns p e r mm e m b r a n e .I t
could therefore be proposed that the concentration of
GSH could be used as a chemical parameter to assess
male fertility. The beneficial role of GSH to minimize
oxidative damage to the spermatozoa can make it a sui-
table candidate for therapeutic usage in the treatment of
male infertility.
Altered antioxidant status was observed in the seminal
plasma, which was collected during our study from
infertile men. This might cause oxidative damage and
makes the sperm highly susceptible to lipid peroxida-
tion. MDA production reflects the peroxidation of mem-
brane polyunsaturated phospholipids [32,33]. Our results
established a significant increase in the amount of semi-
nal MDA in abnormal groups compared to normozoos-
permics. Accordingly, lipid peroxidative degradation of
sperm membrane integrity may be held responsible for
abnormal sperm motility, concentration and morphol-
ogy. Our results were corroborative with Hesham et al.
[3] and Ben Abdallah F et al. [34] who reported that
MDA content was elevated in oligozoospermic and
asthenozoospermic groups. However, there was contro-
versy about seminal MDA activity and sperm quality.
We showed that higher seminal MDA levels were nega-
tively associated with sperm motility and sperm count.
Nevertheless, a positive relationship was observed
between increased lipid peroxidation and the abnormal
sperm morphology, which was compatible with the find-
ings of Suleiman et al. [35]. Increased MDA levels in
seminal plasma of abnormal groups could represent the
pathological effects lipid peroxidation has on the sper-
matozoa membrane and consequently on sperm motility
and viability.
Conclusions
In summary, associations of seminal Zn, Se and GSH
with other parameters of semen quality indicate that the
decrease of seminal antioxidants can be a risk factor for
sperm abnormality and idiopathic male infertility. It was
also shown that increased MDA levels in the abnormal
groups could represent the pathological effects of lipid
peroxidation on sperm function. These data suggested
that routine determination of antioxidant status during
infertility investigation is recommended. Furthermore,
future research should focus on enzymatic and non-
enzymatic antioxidants; genetic susceptibility and their
repercussions on semen quality.
Abbreviations
ROS: Reactive Oxygen Species; PUFAs: Polyunsaturated Fatty Acids; MDA:
Malondialdehyde Acid; SOD: Superoxide Dismutase; GPX: Glutathione
peroxidase; GRD: Glutathione peroxidase; GSH: Glutathione; Zn: Zinc; DNA:
Desoxirubonucleic Acid; Se: Selenium; GSHt: Total glutathione; GSHr:
Reduced glutathione; GSSG: Oxidized glutathione; Normo: Normozoospermic
men; Astheno: Asthenozoospermic men; Oligo: Oligozooseprmic men;
Terato: Teratozoospermic men; AAS: Atomic Absorption Spectroscopy; TBA:
Thiobarbituric Acid; SD: Standard Deviation; Max: Maximum; Min: Minimum;
NS: Not Significant.
Acknowledgements
We want to thank Dr. Monia Raffa (Research Laboratory of “Trace elements,
free radicals and antioxidants”, Biophysical Department, Faculty of Medicine,
Monastir, Tunisia) for her help and assistance during biochemical analysis.
Author details
1Unit of Reproductive Medicine, University Farhat Hached Hospital, 4000
Soussa, Tunisia.
2Research Laboratory of “Trace elements, free radicals and
antioxidants”, Biophysical Department, Faculty of Medicine, University of
Monastir, 5000 Monastir, Tunisia.
3Department of Cytogenetic and
Reproductive Reproduction, Farhat Hached, University Teaching Hospital,
4000 Sousse, Tunisia.
Authors’ contributions
All the authors made substantial contributions to the design and conception
of the study. Particularly, FA wrote the manuscript, contributed to the
analysis and interpretation of the data. AK conceived of the study, and
participated in its design and coordination and helped to draft the
manuscript. MA contributed to the development of the protocol and study
instruments. All the authors have been involved in drafting and revising the
manuscript, have read, and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Atig et al. BMC Urology 2012, 12:6
http://www.biomedcentral.com/1471-2490/12/6
Page 7 of 8Received: 13 November 2011 Accepted: 19 March 2012
Published: 19 March 2012
References
1. Chaudhari AR, Das P, Singh R: Study of oxidative stress and reduced
glutathione levels in seminal plasma of human subjects with different
fertility potential. Biomed Res 2008, 19:207-210.
2. Agarwal A, Sharma R, Nalella KP, Thomas AJ, Alvarez JG, Sikka SC: Reactive
oxygen species as an independent marker of male factor infertility. Fertil
Steril 2006, 86:878-885.
3. Hesham N, Moemen LA, Abu Elela MH: Studying the levels of
malondialdehyde and antioxidant parameters in normal and abnormal
human seminal plasma. Aust J Basic Appl Sci 2008, 2:773-778.
4. Agarwal A, Saleh RA, Bedaiwy MA: Role of reactive oxygen species in the
pathophysiology of human reproduction. Fertil Steril 2003, 79:829-843.
5. Potts RJ, Notarianni LJ, Jefferies TM: Seminal plasma reduces exogenous
oxidative damage to human sperm, determined by the measurement of
DNA strand breaks and lipid peroxidation. Mutat Res 2000, 447:249-256.
6. Colagar AH, Marzony ET, Chaichi MJ: Zinc levels in seminal plasma are
associated with sperm quality in fertile and infertile men. Nutr Res 2009,
29:82-88.
7. Chia SE, Ong CN, Chua LH, Ho LM, Tay SK: Comparison of zinc
concentrations in blood and seminal plasma and the various sperm
parameters between fertile and infertile men. J Androl 2000, 21:53-57.
8. Ebisch IMW, Thomas CMG, Peters WHM, Braat DDM, Steegers-
Theunissen RPM: The importance of folate, zinc and antioxidants in the
pathogenesis and prevention of subfertility. Hum Reprod Update 2007,
13:163-174.
9. Akinloye O, Arowojolu O, Shittu B, Adejuwon CA, Osotimehin B: Selenium
Status of Idiopathic Infertile Nigerian Males. Biol Trace Elem Res 2005,
104:9-18.
10. Agarwal A, Sekhon LH: Oxidative stress and antioxidants for idiopathic
oligoasthenoteratospermia: Is it justified? Indian J Urol 2011, 27:74-85.
11. Sørensen MB, Stoltenberg M, Danscher G, Ernst E: Chelation of intracellular
zinc ions affects human sperm cell motility. Mol Hum Reprod 1999,
5:338-341.
12. Bhardwaj A, Verma A, Majumdar S, Khanduja KL: Status of Vitamin E and
reduced glutathione in semen of Oligozoospermic & azoospermic
patients. Asian J Androl 2000, 2:225-228.
13. World Health Organization: WHO laboratory manual for the examination of
human semen and semen-cervical mucus interaction. 4 edition. Cambridge,
UK: Published on behalf of the World Health Organization by Cambridge
University Press; 1999, 1-86.
14. David G: Editorial: sperm banks in France. Arch Fr Pediatr 1975, 5:401-404.
15. Akerboom TPM, Sies H: Assay of glutathione disulfide and glutathione
mixed disulfides in biological samples. Methods Enzymol 1981, 77:373-378.
16. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma.
Biochem Med 1976, 5:212-216.
17. Lewis-Jones DL, Aird IA, Biljan MM, Kingsland CR: Effects of sperm activity
on zinc and fructose concentrations in seminal plasma. Hum Reprod
1996, 11:2465-2467.
18. Kruse WE, Zwick EM, Batschulat K, Rohr G, Ambruster FP, Petzoldt D, et al:
Are zinc levels in seminal plasma associated with seminal leukocytes
and other determinants of semen quality? Fertil Steril 2002, 77:260-269.
19. Omu AE, Dashti H, Al-Othman S: Treatment of asthenozoospermia with
zinc sulphate: andrological, immunological and obstetric outcome. Eur J
Obstet Gynecol Reprod Biol 1998, 79:179-184.
20. Dissanayake D, Wijesinghe P, Ratnasooriya W, Wimalasena S: Relationship
between seminal plasma zinc and semen quality in a sub-fertile
population. J Hum Reprod 2010, 3:124-128.
21. Powell SR: Antioxidant properties of zinc. J Nutr 2000, 130:1447-1454.
22. Zhao RP, Xiong CL: Zinc content analysis in serum, seminal plasma and
spermatozoa of asthenozoospermic and oligoasthenozoospermic
patients. Zhonghua Nan Ke Xue 2005, 11:680-682.
23. Boitani C, Puglisi R: Selenium, a Key Element in Spermatogenesis and
Male Fertility. Adv Exp Med Biol 2008, 636:65-73.
24. Saaranen M, Suistomaa U, Vanha-Perttula T: Semen selenium content and
sperm mitochondrial volume in human and some animal’s species. Hum
Reprod 1989, 4:504-508.
25. Takasaki N, Tonami H, Simizu A, Ueno N, Ogita T, Okada S, et al: Semen
selenium and infertility. Bull Osaka Med Sch 1987, 33:87-96.
26. Bedwal RS, Bahuguna A: Zinc, copper and selenium in reproduction.
Experientian 1994, 50:626-640.
27. Sunde RA: The biochemistry of selenoproteins. J Am Oil Chem Soc 1984,
61:1891-1900.
28. Ochsendorf FR, Buhl R, Bästlein A, Beschmann H: Glutathione in
spermatozoa and seminal plasma of infertile men. Hum Reprod 1998,
13:353-359.
29. Lenzi A, Gandini L, Picardo M: A rationale for glutathione therapy. Hum
Reprod 1998, 13:1419-1422.
30. Raijmakers MT, Roelofs HM, Steegers EA, Steegers-Theunissen RRP,
Mulder TP, Knapen MF, et al: Glutathione and glutathione S-transferases
A1-1 and P1-1 in seminal plasma may play a role in protecting against
oxidative damage to spermatozoa. Fertil Steril 2003, 79:169-172.
31. Eskiocak S, Gozen AS, Yapar SB, Tavas F, Kilic AS, Eskiocak M: Glutathione
and free sulphydryl content of seminal plasma in healthy medical
students during and after exam stress. Hum Reprod 2005, 9:2595-6000.
32. Storey BT: Biochemistry of the induction and prevention of lipo-
peroxidative mechanisms damage in human spermatozoa. Mol Hum
Reprod 1997, 3:203-213.
33. Agarwal A, Allamaneni SS: Free radicals and male reproduction. J Indian
Med Assoc 2011, 109:184-187.
34. Ben Abdallah F, Dammak I, Attia H, Hentati B, Ammar-Keskes L: Lipid
peroxidation and antioxidant enzyme activities in infertile men:
correlation with semen parameter. J Clin Lab Anal 2009, 23:99-104.
35. Suleiman SA, Ali ME, Zaki ZM, El Malik EM, Nasr MA: Lipid peroxidation
and human sperm motility: protective role of vitamin E. J Androl 1996,
17:530-537.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2490/12/6/prepub
doi:10.1186/1471-2490-12-6
Cite this article as: Atig et al.: Impact of seminal trace element and
glutathione levels on semen quality of Tunisian infertile men. BMC
Urology 2012 12:6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Atig et al. BMC Urology 2012, 12:6
http://www.biomedcentral.com/1471-2490/12/6
Page 8 of 8